- Home
- LXEH vs EVGN Comparison
LXEH vs EVGN Comparison
Compare LXEH & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEH
- EVGN
- Stock Information
- Founded
- LXEH 2001
- EVGN 1999
- Country
- LXEH China
- EVGN Israel
- Employees
- LXEH N/A
- EVGN N/A
- Industry
- LXEH Other Consumer Services
- EVGN Agricultural Chemicals
- Sector
- LXEH Real Estate
- EVGN Industrials
- Exchange
- LXEH Nasdaq
- EVGN Nasdaq
- Market Cap
- LXEH 12.5M
- EVGN 10.9M
- IPO Year
- LXEH 2020
- EVGN N/A
- Fundamental
- Price
- LXEH $0.37
- EVGN $1.30
- Analyst Decision
- LXEH
- EVGN Strong Buy
- Analyst Count
- LXEH 0
- EVGN 1
- Target Price
- LXEH N/A
- EVGN $3.50
- AVG Volume (30 Days)
- LXEH 2.4M
- EVGN 142.6K
- Earning Date
- LXEH 09-26-2025
- EVGN 11-20-2025
- Dividend Yield
- LXEH N/A
- EVGN N/A
- EPS Growth
- LXEH N/A
- EVGN N/A
- EPS
- LXEH N/A
- EVGN N/A
- Revenue
- LXEH $4,585,942.00
- EVGN $9,444,000.00
- Revenue This Year
- LXEH N/A
- EVGN N/A
- Revenue Next Year
- LXEH N/A
- EVGN $12.35
- P/E Ratio
- LXEH N/A
- EVGN N/A
- Revenue Growth
- LXEH N/A
- EVGN 42.25
- 52 Week Low
- LXEH $0.31
- EVGN $0.95
- 52 Week High
- LXEH $50.08
- EVGN $2.87
- Technical
- Relative Strength Index (RSI)
- LXEH 22.81
- EVGN 53.55
- Support Level
- LXEH $0.31
- EVGN $1.23
- Resistance Level
- LXEH $0.38
- EVGN $1.49
- Average True Range (ATR)
- LXEH 0.28
- EVGN 0.10
- MACD
- LXEH -0.13
- EVGN 0.00
- Stochastic Oscillator
- LXEH 1.70
- EVGN 50.00
About LXEH Lixiang Education Holding Co. Ltd.
Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.